Tag: Hepatitis
HBV Reactivation Is Concern With DAA Tx in HBV-HCV Coinfection
29 cases of HBV reactivation reported in patients with coinfection receiving direct-acting antivirals
Hep B, C Could Be Eliminated As Public Health Threats by 2030
Tools exist to prevent hepatitis B and C mortality, including vaccination and treatment
Hepatitis B, C Linked to Higher Subsequent Rates of Parkinson’s
Increased rates of subsequent Parkinson's for those with hepatitis B, C, but not autoimmune hepatitis
Review: Multiple DAA Regimens Effective for HCV Genotype 1
Six DAA regimens show high SVR in HCV genotype 1 without cirrhosis, even with HIV co-infection
HBV Reactivation Seen With DAA Treatment of Chronic Hep C
HBV virological reactivation in four of seven patients with current HBV infection; none with past infection
Rates of Hepatitis C Testing Too Low in Baby Boomers
Screening rates remain low despite recommendations, researchers say
Short-Course Tocilizumab May Up Hep B Reactivation in RA
Three patients with chronic HBV infection had reactivation, but they were asymptomatic
Risk of Diabetes Down With HCV SVR in HIV/HCV Coinfection
Sustained viral response linked to reduction in risk of diabetes, trend toward reduced risk of renal failure
Sorafenib Effect on HCC Survival Depends on Hepatitis Status
Findings in meta-analysis of individual patient data for advanced unresectable hepatocellular carcinoma
Non-Liver-Related Critical Events Down With SVR in HCV+Cirrhosis
Study confirms reduction in critical events, liver-related or not
